Skip to main content
. 2022 May 27;67(11):5137–5148. doi: 10.1007/s10620-022-07543-3

Fig. 6.

Fig. 6

No differences in fecal acetate (A), propionate (B), and butyrate (C) between controls and IBS, and severity groups over time, but lower level acetate in constipation-predominant IBS patients. Values were presented as interquartile with boxplot. Significance between groups was test by Wilcoxon. * p < 0.05; ** p < 0.01